WO2014188453A3 - Novel process for the preparation of 2-[4-(2-{4-[1-(2-ethoxyethyl)-1h-benzimidazol-2-yl]-1-piperidinyl}ethyl) phenyl]-2-methylpropanoic acid - Google Patents
Novel process for the preparation of 2-[4-(2-{4-[1-(2-ethoxyethyl)-1h-benzimidazol-2-yl]-1-piperidinyl}ethyl) phenyl]-2-methylpropanoic acid Download PDFInfo
- Publication number
- WO2014188453A3 WO2014188453A3 PCT/IN2014/000353 IN2014000353W WO2014188453A3 WO 2014188453 A3 WO2014188453 A3 WO 2014188453A3 IN 2014000353 W IN2014000353 W IN 2014000353W WO 2014188453 A3 WO2014188453 A3 WO 2014188453A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- preparation
- benzimidazol
- ethoxyethyl
- piperidinyl
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/317—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
The present invention relates to novel process for the preparation of 2-[4-(2-{4-[l-(2- ethoxyethyl)-lH-benzimidazol-2-yl]-l-piperidinyl}ethyl)phenyl]-2-methylpropanoic acid represented by the following structural formula- 1. Formula- 1 The present invention also provides novel intermediate compounds useful for the preparation of compound of formula- 1.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2276/CHE/2013 | 2013-05-24 | ||
IN2276CH2013 | 2013-05-24 | ||
IN5394/CHE/2013 | 2013-11-22 | ||
IN5394CH2013 IN2013CH05394A (en) | 2013-11-22 | 2014-05-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2014188453A2 WO2014188453A2 (en) | 2014-11-27 |
WO2014188453A3 true WO2014188453A3 (en) | 2015-02-26 |
Family
ID=51934282
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2014/000353 WO2014188453A2 (en) | 2013-05-24 | 2014-05-26 | Novel process for the preparation of 2-[4-(2-{4-[1-(2-ethoxyethyl)-1h-benzimidazol-2-yl]-1-piperidinyl}ethyl) phenyl]-2-methylpropanoic acid |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2014188453A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106699728A (en) * | 2015-07-13 | 2017-05-24 | 南京长澳医药科技有限公司 | Bilastine intermediate impurity and preparation method thereof |
CN105254579A (en) * | 2015-09-19 | 2016-01-20 | 万全万特制药江苏有限公司 | Method for preparing bilastine intermediate through one-kettle process |
WO2018042305A1 (en) * | 2016-08-29 | 2018-03-08 | Symed Labs Limited | Improved processes for preparation of bilastine using novel intermediates |
CN106631687B (en) * | 2016-12-21 | 2019-08-30 | 山东新和成药业有限公司 | A method of with synthesizing leaf alcohol under silane-Lewis acid catalytic systems |
CN107365298A (en) * | 2017-03-14 | 2017-11-21 | 罗欣生物科技(上海)有限公司 | A kind of preparation method of the benzyl propionate derivant of 2 methyl 2 ' |
CN109810093A (en) * | 2017-11-20 | 2019-05-28 | 重庆华邦胜凯制药有限公司 | A kind of preparation method of bilastine intermediate |
EP3599235A1 (en) | 2018-07-24 | 2020-01-29 | Faes Farma, S.A. | Process and intermediates for the preparation of bilastine |
CN110950837A (en) * | 2018-09-27 | 2020-04-03 | 上海天慈中商药业有限公司 | Preparation method of bilastine |
CN111039784A (en) * | 2019-12-18 | 2020-04-21 | 厦门云凡医药科技有限公司 | Preparation method of bilastine intermediate |
CN111039922A (en) * | 2019-12-27 | 2020-04-21 | 山东罗欣药业集团恒欣药业有限公司 | Preparation process of bilastine |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5877187A (en) * | 1996-06-04 | 1999-03-02 | Fabrica Espanola De Productos Quimicos Y Farmaceuticos S.A. (Faes) | Benzimidazole derivatives with antihistaminic activity |
US7612095B2 (en) * | 2002-04-19 | 2009-11-03 | Faes Farma, S.A. | Polymorph of 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazole-2-yl]-1-piperidinyl]ethyl]-αα-dimethyl-benzeneacetic acid |
-
2014
- 2014-05-26 WO PCT/IN2014/000353 patent/WO2014188453A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5877187A (en) * | 1996-06-04 | 1999-03-02 | Fabrica Espanola De Productos Quimicos Y Farmaceuticos S.A. (Faes) | Benzimidazole derivatives with antihistaminic activity |
US7612095B2 (en) * | 2002-04-19 | 2009-11-03 | Faes Farma, S.A. | Polymorph of 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazole-2-yl]-1-piperidinyl]ethyl]-αα-dimethyl-benzeneacetic acid |
Also Published As
Publication number | Publication date |
---|---|
WO2014188453A2 (en) | 2014-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2014188453A3 (en) | Novel process for the preparation of 2-[4-(2-{4-[1-(2-ethoxyethyl)-1h-benzimidazol-2-yl]-1-piperidinyl}ethyl) phenyl]-2-methylpropanoic acid | |
IL257390B (en) | Salts of 1-((4-(methoxymethyl)-4-(((1r,2s)-2-phenyl-cyclopropylamine)methyl) piperidin-1-yl)methyl)-cyclobutane-carboxylic acid as lsd1 inhibitor | |
DK2285765T3 (en) | Process for the preparation of derivatives of 1- (2-halobiphenyl-4-yl) -cyclopropane carboxylic acid | |
WO2012138147A3 (en) | 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid crystalline form and the producing method thereof | |
EA201891396A1 (en) | Method of producing 2- [4- (4-chlorophenoxy) -2- (trifluoromethyl) phenyl] -1- (1,2,4-triazole-1-il) propane-2-ola | |
TW201129555A (en) | Process for the manufacture of dabigatrane etexilate | |
UA111725C2 (en) | CRYSTAL (R) - (E) -2- (4- (2- (5- (1- (3,5-Dichloropyridin-4-yl) ethoxy) -1H-indazol-3-yl) vinyl) -1H- PYRAZOL-1-IL) ETHANOL | |
MX2013003558A (en) | Crystalline oxalate salts of a diamide compound. | |
MX2012000682A (en) | Crystalline freebase forms of a biphenyl compound. | |
UA106619C2 (en) | A process for producing 1- (2-halogen biphenyl-4-yl) cyclopropanecarboxylic acid | |
CL2011000296A1 (en) | Process for preparing 4-oxo-octahydro-indole-1-carboxylic acid methyl ester and intermediate compounds used. | |
NZ702797A (en) | Method for producing 4-[5-(pyridin-4-yl)-1h-1,2,4-triazol-3-yl]pyridine-2-carbonitrile, and intermediate thereof | |
HK1168102A1 (en) | Process for the preparation of a compound useful as an inhibitor of tafia | |
MX350024B (en) | Polymorph form of 4-{[4-({[4-(2,2,2-trifluoroethoxy)-1,2-benzisox azol-3-yl]oxy}methyl)piperidin-1-yl]methyl}-tetrahydro-2h-pyran- 4-carboxylic acid. | |
WO2014049612A3 (en) | Processes and polymorphs of 5-[4-[4-(5-cyano-1h-indol-3-yl) butyl]-1-piperazinyl]-2-benzofuran carboxamide and its salts | |
MX2010009926A (en) | New process for the preparatiion of cyclohexanecarboxylic acid dericatives. | |
WO2014087208A3 (en) | A process of preparing alcaftadine | |
MX2014004688A (en) | Process for the preparation of isoxazolyl-methoxy-nicotinic acids. | |
DK2227455T3 (en) | Trisubstituted 3,4-dihydro-1H-isoquinoline compound, method of preparation and its use | |
MX2013011151A (en) | Process for the preparation of 1 - ( 2 -methyl - 4 - ( 2, 3, 4, 5 - tetrahydro - 1 - benzazepin- 1 -ylcarbonyl) benzylcarbamoyl) - l - proline - n, n- dimethylamide. | |
CL2009001437A1 (en) | Method for the preparation of (1r, 2s, 3r) -1- (2- (isoxazol-3-yl) -1h-imidazol-5-yl) butane-1,2,3,4-tetraol using isoxazol-3- carbonitrile; and one of the intermediate compounds considered in the preparation of isoxazole-3-carbonitrile. | |
UY35503A (en) | TITLE: PROCEDURE FOR THE SYNTHESIS OF DERIVATIVES OF 7,8-DIMETOXI-1,3-DIHIDRO-2H-3- BENZAZEPIN -2- ONA AND APPLICATION TO THE SYNTHESIS OF IVABRADINE | |
MX352295B (en) | Substituted phenyl compounds. | |
IN2013CH06150A (en) | ||
WO2014167578A3 (en) | Novel polymorph of isobutyric acid 2-((r)-3-diisopropyl amino-1-phenylpropyl)-4-(hydroxymethyl)phenyl ester hydrochloride and process for preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14801659 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 14801659 Country of ref document: EP Kind code of ref document: A2 |